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Abstract
In recent studies, two distinct mechanisms have been proposed to account for major
histocompatibility complex (MHC) restriction of T-cell activity: (a) evolution-driven interactions
between T-cell receptor (TCR) variable regions and MHC, and (b) a requirement for CD4 or CD8
binding to MHC to initiate signalling through the TCR complex. Both mechanisms are likely to be
essential, but for different reasons.
Introduction and context
Since the discovery that T cells are restricted by products
of the major histocompatibility complex (MHC) [1],
there has been considerable interest in understanding
their molecular and structural basis. The process that
yields a T-cell repertoire restricted to MHC ligands occurs
in the thymus and is called positive selection [2]. Simply
put, if the ab T-cell receptor (TCR) does not have some
basal binding affinity for MHC, then the T cell dies.
Despite two decades of study, the underlying mechanism
that accounts for MHC restriction by T cells has remained
unclear and, to some extent, controversial. In the last
several years, two mechanisms that could account for
MHC restriction and positive selection have made their
way to the forefront. One mechanism involves observa-
tions that germline-encoded TCR variable (V) regions
appear to have evolved residues that interact with the
MHC. The other mechanism relies on a signalling
requirement: the TCR/CD3 complex must be brought
together with the co-receptors CD4 or CD8 upon co-
binding of the MHC product. While in principle one
could make the case that one of these proposed
mechanisms is more important than the other, various
considerations (including the low affinity threshold for
positive selection and the diversity of TCRs) lead to the
conclusion that both mechanisms are important.
Major recent advances
Germline-encoded TCR regions evolved to
bind MHC products
Based on various studies, it was reasonable to expect that
the structures of a collection of TCR:pepMHC complexes
would reveal a clear mechanistic basis of MHC restriction
[3-6]. For example, there could have been contacts
between conserved TCR residues and conserved regions
of MHC and these interactions could have accounted not
only for MHC restriction, but for the ability of a TCR to
distinguish class I from class II MHCs. To the surprise of
many, there were few discernable atomic interactions
that were conserved, although there was a conserved,
roughly diagonal docking pattern of TCR on MHC [7-9].
In hindsight, these structural analyses were complicated
by the diversity of TCRs and the variety of pepMHC
ligands that were represented among the complexes.
Once several TCR:pepMHC structures that shared TCR
regions were compared, Garcia and colleagues [10-12]
were able to identify a few conserved pairs of interactions
(TCR:MHC) that represented germline-encoded recogni-
tion motifs. Several amino acid residues of the comple-
mentarity determining region 1 (CDR1) and CDR2 loops
contacted the helices of the MHC and these interactions
were important energetically. Accordingly, it was pro-
posed that each V region might have evolved a few key
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anMHCmolecule(Figure1a,b).Inthismodel,ithasbeen
suggested that the same V region might have evolved
different contacts with a different allele, as in the case of
the 2C TCR recognizing K
b compared with L
d [13]. To
date, these TCR regions have focused mostly on the Vb,
althoughthere is some evidence that Va regions may also
be involved [5,14]. Thus, the conserved diagonal orienta-
tion of TCRs on MHC could be a consequence of these
evolution-driven V-region interactions with the cor-
responding helices of the class I or class II MHC ligands.
Kappler, Marrack, Gapin, and their colleagues soon
verified this result at the structural level [15,16] and
provided acomparative analysis of conserved amino acid
residues among the repertoire of V-region genes [14]. In
a key follow-up to the structural studies, they recently
reported that the mutation of several of these conserved
residues in Vb8.2 (see ‘A case for both mechanisms’
section below) also had a significant quantitative impact
on the positive selection of thymocytes [17], providing
evidence of the physiological importance of these
residues in interactions with MHC.
Finally, in a series of studies by Rossjohn, McCluskey,
and colleagues [18], it is clear that the biased usage of
TCR gene segments against a specific pepMHC is a
product of many factors, including the antigen peptide
itself and the MHC-restricting element. In a recent study
comparing the structures of two Epstein-Barr virus
(EBV)-specific TCRs, they showed that the process of
negative selection (in their example, against an MHC
allotype) had a significant impact on the ultimate
repertoire of EBV-reactive TCRs that emerged [19]. A
corollary of these findings is that evolution-driven TCR
V-region binding to particular MHC alleles could be so
strong as to lead to the deletion of T cells bearing these
TCRs in the thymus. It is important to note that this same
group has shown that at least some TCR:pepMHC
interactions have energetic profiles that focus more on
CDR3 interactions rather than those of CDR1 and CDR2
[20]. Thus, a strict evolution-based model of germline
V-region interactions for all TCRs may be an over-
generalization. In these cases, the co-receptor mechanism
described below may be more critical.
CD4 and CD8 co-receptors ensure MHC restriction
of TCRs
An alternative mechanism that could drive the conserved
docking orientation, and one that (in principle) is
consistent with the absence of universally conserved
atomic interactions, involves the requirement for co-
receptors CD4 and CD8 [21,22]. Recently, Singer and
colleagues [23] generated mice deficient in CD4, CD8,
class I MHC, and class II MHC and showed that the mice
contained a diverse repertoire of T cells that were not
restrictedbyMHC.Toaccountforthis,theyproposedthat
sequestration of the lymphocyte-specific tyrosine kinase
(Lck)byCD4andCD8candictateselectionforTCR:MHC
binding by preventing signalling by non-MHC ligands.
In this model, only TCRs that bind to an MHC molecule
will be capable of bringing the CD4 or CD8 molecules
into proximity with the TCR/CD3 complex, thereby
allowing the associated Lck to initiate the signalling
process through CD3 (Figure 2a). Those TCRs that bind
to non-MHC molecules would not be capable of
recruiting CD4/Lck or CD8/Lck to the TCR/CD3 complex
(Figure 2b). If one assumes that co-receptor and/or CD3
Figure 1. Germline-encoded residues in CDR1 and/or CDR2 of
TCR variable (V) regions evolved to interact with MHC
(a) A class I MHC allele (X) is contacted by a few residues from the Va and
Vb of TCR1. A different TCR, TCR 2, might contain different residues from
its Va and Vb that contact the same MHC allele. The lines extending
between V regions and MHC helices represent atomic interactions of
varying strengths (denoted by widths). (b) The same TCRs from (a) might
have evolved a slightly modified set of residue interactions with a different
MHC allele (Y). (c) In the structure of the 2C TCR:SIY/K
b, the CDR2b loop
contains three residues, Y46, Y48, and E54, that have been implicated in the
positive selection of class I and/or II molecules. In an alanine scan of the 2C
TCR, residues Y46 and Y48 were shown to contribute significant binding
energy, whereas E54 did not. As described in the ‘A case for both
mechanisms’ section, only a few atomic interactions such as these could
contribute the majority of the binding energy in positive selection. CDR,
complementarity determining region; MHC, major histocompatibility
complex; TCR, T-cell receptor.
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binding of the TCR and co-receptor to the same MHC
molecule, then one could imagine the need for a
conserved diagonal imprint of TCR on the pepMHC.
A case for both mechanisms: affinity threshold of positive
selection, TCR diversity, and binding energetics
Which of these two mechanisms is more important for
MHC restriction by T cells? The discussion to follow is
based on two primary considerations. First, the TCR:
MHC interaction affinity required for positive selection
has been evolutionarily set to be quite low [24]. Second,
the extensive diversity of TCRs, like antibodies, is likely
to allow low-affinity interactions with many different
ligands (sometimes referred to as polyspecificity [25]).
As indicated above, the affinity threshold for positive
selection has been estimated to be quite low (in the
range of 10
4/M) [26,27]. Thus, thymocytes have evolved
an exquisite sensitive mechanism for guiding the
selection process [28]. This low affinity threshold allows
a set of minimal conserved interactions between TCR
and MHC to be effective. In this regard, it is worth
considering whether the proposed evolution-driven
atomic interactions (for example, Y46 and Y48 of
mouse Vb8.2) contribute sufficient binding energy to
drive positive selection. Alanine scans of the 2C TCR,
which contains Vb8.2 and has been studied in detail
structurally [13,29,30], have been performed for binding
to both a syngeneic ligand K
b and an allogeneic ligand L
d
[31,32]. The binding energies associated with the two key
CDR2b residues Y46 and Y48 (Y48 and Y50 in [31,32])
were each shown to be 1.5 kcal/mol or greater (that is,
no binding was observed for the alanine mutants)
(Figure 1c). Another residue in CDR2b of Vb8.2 which
has been shown to be important in class II binding, E54,
was actually shown to have a negative effect on binding
to QL9/L
d (residue E56 in [31,33]), and mutation of this
residue to alanine had a diminished effect on positive
selection of CD8
+ cells in the recent work [17].
The net effect of the two residues Y46 and Y48 (assuming
no cooperative effects) would be at least 3 kcal/mol.
Residue N29b (N31b in [31]) also had an impact of
1.5 kcal/mol, and several Va3.1 CDR1 and CDR2
residues had significant effects. Are the binding energies
associated with only a few atomic interactions sufficient
to make a substantial contribution, perhaps even the
dominant contribution, to positive selection? Based
purely on the TCR:MHC affinities reported to be
responsible for positive selection, the answer is yes.
Thus, at a KA value of 10
4/M, the binding free energy of
positive selection interactions would be in the range of
5.4 kcal/mol (calculated from DG=−RT ln KA). Even the
interactions associated with only Y46b, Y48b, and N29b
would contribute the majority of this binding energy.
Clearly, the basal binding energies associated with
conserved interactions would be influenced, either
negatively or positively, by adjacent CDRs (including
CDR3s) or by the peptide bound to the MHC product
[18,20,34,35].
What would be the probability that a TCR would have a
basal binding affinity of 10
4/M for an MHC molecule if
there were not an evolutionarily-based selection of V
region:MHC interactions? While there are no data to
provide guidance here, it would seem that this would be
a highly infrequent event and that reliance on random
chance would be a considerable waste in terms of the
number of thymocytes necessary to yield such interac-
tions. Furthermore, the conserved diagonal docking
angle indicates that orientation is not random, further
reducing the probability of a chance encounter with
adequate affinity between TCR and MHC (that is, in just
the right orientation).
Notwithstanding the arguments in favor of evolved V
region:MHC binding interactions, the low affinity
threshold of positive selection also requires that a
mechanism be in place to ensure that TCR interactions
with non-MHC ligands do not lead to positive selection.
The very same TCR diversity that allows a broad response
against foreign antigens would enable such interactions.
Figure 2. The requirement for CD4 or CD8 binding to MHC
ensures that the TCR does not interact with non-MHC ligands
(a) When the TCR has some minimal affinity for a class I MHC, CD8 binding
to the same MHC molecule drives the proximal signalling necessary for
positive selection through the action of the associated kinase Lck that
phosphorylates CD3 subunits. (b) When the TCR binds to a non-MHC
ligand, the CD8/Lck complex is unable to associate with the TCR/CD3
complex and signalling does not occur. Lck, lymphocyte-specific tyrosine
kinase; MHC, major histocompatibility complex.
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the frequency of such reactivities of the TCR repertoire, it
is useful to examine what we know about this with
antibodies, since germline (non-mutated) antibodies are
similar to TCRs in terms of diversity. It has been reported
that a single germline antibody could react with up to
1% of a protein library derived from cDNA [36]. (Note:
the affinities of these interactions were not reported, but
it is reasonable to guess that they were at least 10
4/M or
binding would not have been detected.) Furthermore, it
has been shown that diversity in a single CDR3H (CDR of
the antibody heavy chain) region (that is, identical
germline regions) was capable of generating reactivity
with virtually any antigen tested [37].
Accordingly, it is reasonable to predict that TCRs would
have a high frequency of low affinity for other cell surface
molecules (consistent with the observations in [23]). The
low affinity threshold necessary for positive selection
makes it even more likely that such interactions would
occur. Thus, it is imperative that a precise mechanism
such as CD4/CD8 co-receptor sequestration of Lck be in
place to avoid positive selection of TCRs with such
reactivities, even if the V-region repertoire has been
evolutionarily selected for interactions with MHC.
Future directions
To further support the concept of evolution-driven V
region:MHC interactions, it will be important to examine
many more structures of TCR:pepMHC complexes,
focusing on TCRs with the same V region (Va and/or
Vb) in complexes with diverse ligands. These ligands
should include different peptides bound to the same
MHC, different MHC alleles, and both class I and class II
MHCs. It would also be useful to examine TCRs isolated
through in vitro selections of germline V-region libraries
[38] for binding to MHC products, in the absence of co-
receptors. This could reveal the role of CD4 or CD8 in
guiding the docking orientation (for example, if the
diagonal were not observed, one would predict a
significant role of CD4 and CD8). Finally, additional
thymic development studies with TCRs containing
selected point mutations [17] would assess how broadly
these findings can be extended to other V regions.
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